Mosapride Dispersible Tablets, or Mosapride Citrate Dispersible Tablets, are suitable for the treatment of symptoms associated with functional dyspepsia. Mosapride Citrate Dispersible Tablets is a selective 5-hydroxytryptamine 4 receptor agonist that promotes gastric and duodenal motility and accelerates gastric emptying, and is mainly used for the treatment of functional dyspepsia accompanied by gastrointestinal symptoms such as belching, nausea, vomiting, early satiety, heartburn, epigastric distension, epigastric pain and so on. The drug is contraindicated in people who are allergic to the product. After the use of the drug, the main adverse reactions such as diarrhea, abdominal pain, dry mouth, rash, lethargy, dizziness and other adverse reactions appear. Specific medication should be carried out under the guidance of a specialist, not unauthorized use of medication, the use of medication for 2 weeks without significant improvement should be discontinued to consult a doctor.